Cervical Cancer

+ -Text Size

Early Detection, Diagnosis, and Staging TOPICS

Survival rates for cervical cancer, by stage

Survival rates are often used by doctors as a standard way of discussing a person's prognosis (outlook). Some patients with cancer may want to know the survival statistics for people in similar situations, while others may not find the numbers helpful, or may even not want to know them. If you do not want to know them, stop reading here and skip to the next section.

The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Of course, many people live much longer than 5 years (and many are cured). Also, these are observed survival rates and include deaths from any cause. People with cancer may die from things other than cancer, and these rates don’t take that into account.

In order to get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago. Improvements in treatment since then may result in a more favorable outlook for people now being diagnosed with cervical cancer.

Survival rates are often based on previous outcomes of large numbers of people who had the disease, but they cannot predict what will happen in any particular person's case. Many other factors can affect a person's outlook, such as their general health and how well the cancer responds to treatment. Your doctor can tell you how the numbers below may apply to you, as he or she is familiar with the aspects of your particular situation.

The rates below are based on the stage of the cancer at the time of diagnosis. Your doctor can give you information about what kind of survival you may be able to expect if your cancer has come back or progressed.

The rates below were published in 2010 in the 7th edition of the AJCC staging manual. They are based on data collected by the National Cancer Data Base from people diagnosed between 2000 and 2002. These are the most recent statistics available for survival by the current staging system.

    Stage

    5-Year
    Observed
    Survival Rate

    0

    93%

    IA

    93%

    IB

    80%

    IIA

    63%

    IIB

    58%

    IIIA

    35%

    IIIB

    32%

    IVA

    16%

    IVB

    15%


Last Medical Review: 09/19/2014
Last Revised: 10/13/2014